Fayez Sarofim & Company Has Decreased By $375,410 Its Xilinxinc (XLNX) Position; Select Medical Holdings (SEM) Had 4 Analysts Last Week

January 18, 2018 - By Maria Brooks

Among 9 analysts covering Select Medical Holdings (NYSE:SEM), 4 have Buy rating, 2 Sell and 3 Hold. Therefore 44% are positive. Select Medical Holdings had 25 analyst reports since August 5, 2015 according to SRatingsIntel. The rating was maintained by RBC Capital Markets on Monday, November 2 with “Outperform”. The stock of Select Medical Holdings Corporation (NYSE:SEM) earned “Buy” rating by RBC Capital Markets on Thursday, October 12. Wells Fargo downgraded the stock to “Market Perform” rating in Monday, January 30 report. As per Monday, November 13, the company rating was maintained by RBC Capital Markets. Robert W. Baird maintained it with “Buy” rating and $21.0 target in Sunday, October 15 report. The stock of Select Medical Holdings Corporation (NYSE:SEM) earned “Hold” rating by TheStreet on Friday, October 16. The firm has “Hold” rating by Deutsche Bank given on Monday, August 7. The stock has “Buy” rating by RBC Capital Markets on Monday, August 7. As per Tuesday, October 20, the company rating was upgraded by JMP Securities. Zacks downgraded the shares of SEM in report on Wednesday, August 5 to “Buy” rating. See Select Medical Holdings Corporation (NYSE:SEM) latest ratings:

04/01/2018 Broker: Bank of America Rating: Hold New Target: $19.0 Upgrade
13/11/2017 Broker: RBC Capital Markets Rating: Buy New Target: $19.0 Maintain
06/11/2017 Broker: Deutsche Bank Rating: Buy New Target: $22.0
23/10/2017 Broker: Robert W. Baird Rating: Buy New Target: $25.0 Maintain
15/10/2017 Broker: Robert W. Baird Rating: Buy New Target: $21.0 Maintain
12/10/2017 Broker: RBC Capital Markets Rating: Buy New Target: $19.0 Maintain
11/09/2017 Broker: RBC Capital Markets Rating: Buy New Target: $19.0 Maintain
07/08/2017 Broker: RBC Capital Markets Rating: Buy New Target: $19.0000 Maintain
07/08/2017 Broker: JMP Securities Rating: Market Underperform Old Target: $10 New Target: $12 Maintain
07/08/2017 Broker: Deutsche Bank Rating: Hold Old Target: $20 New Target: $22 Maintain

Fayez Sarofim & Company decreased Xilinxinc (XLNX) stake by 22.18% reported in 2017Q3 SEC filing. Fayez Sarofim & Company sold 5,363 shares as Xilinxinc (XLNX)’s stock rose 11.01%. The Fayez Sarofim & Company holds 18,820 shares with $1.33 million value, down from 24,183 last quarter. Xilinxinc now has $19.11B valuation. The stock increased 0.38% or $0.29 during the last trading session, reaching $76.15. About 168,744 shares traded. Xilinx, Inc. (NASDAQ:XLNX) has risen 52.08% since January 18, 2017 and is uptrending. It has outperformed by 35.38% the S&P500.

The stock decreased 1.70% or $0.3 during the last trading session, reaching $17.35. About 119,529 shares traded. Select Medical Holdings Corporation (NYSE:SEM) has risen 12.50% since January 18, 2017 and is uptrending. It has underperformed by 4.20% the S&P500.

Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates specialty hospitals, outpatient rehabilitation clinics, and occupational medicine centers in the United States. The company has market cap of $2.32 billion. The companyÂ’s Specialty Hospitals segment operates long term acute care hospitals and inpatient acute rehabilitative hospitals. It has a 24.1 P/E ratio. This segment offers various medical services for the treatment of respiratory failure, neuromuscular disorders, traumatic brain and spinal cord injuries, strokes, non-healing wounds, cardiac disorders, renal disorders, and cancer.

Investors sentiment increased to 1.27 in Q3 2017. Its up 0.39, from 0.88 in 2017Q2. It is positive, as 7 investors sold Select Medical Holdings Corporation shares while 53 reduced holdings. 31 funds opened positions while 45 raised stakes. 103.97 million shares or 0.87% less from 104.89 million shares in 2017Q2 were reported. Parkside Finance National Bank & Trust holds 756 shares. Point72 Asia (Hong Kong) holds 0.03% of its portfolio in Select Medical Holdings Corporation (NYSE:SEM) for 2,367 shares. 1.16M were reported by Millennium Mngmt Ltd Liability Corp. Gotham Asset Mngmt Limited has 0.01% invested in Select Medical Holdings Corporation (NYSE:SEM) for 45,437 shares. Hsbc Hldgs Plc holds 0% of its portfolio in Select Medical Holdings Corporation (NYSE:SEM) for 49,476 shares. Northern Trust Corp holds 0.01% of its portfolio in Select Medical Holdings Corporation (NYSE:SEM) for 2.31 million shares. Fifth Third Bancorp holds 0% in Select Medical Holdings Corporation (NYSE:SEM) or 200 shares. Paloma Prtnrs Mngmt holds 0.01% of its portfolio in Select Medical Holdings Corporation (NYSE:SEM) for 27,628 shares. Indexiq Advsrs Ltd Limited Liability Company stated it has 64,924 shares or 0.05% of all its holdings. Menta Lc owns 14,100 shares. Chicago Equity Limited Liability Company invested in 0.03% or 57,545 shares. Shell Asset Management accumulated 148,279 shares or 0.03% of the stock. Geode Capital Mngmt Ltd Company stated it has 889,349 shares. Tci Wealth Advsr Inc owns 160 shares for 0% of their portfolio. First Trust Advisors Limited Partnership holds 52,915 shares or 0% of its portfolio.

Investors sentiment decreased to 0.88 in Q3 2017. Its down 0.16, from 1.04 in 2017Q2. It dived, as 45 investors sold XLNX shares while 194 reduced holdings. 48 funds opened positions while 163 raised stakes. 232.20 million shares or 1.80% less from 236.47 million shares in 2017Q2 were reported. 20,322 are held by Cypress Asset Management Inc Tx. Product Prtnrs Ltd stated it has 129,500 shares or 0.3% of all its holdings. Strs Ohio has 782,154 shares. Bankshares Of Mellon, New York-based fund reported 2.02 million shares. Alliancebernstein Limited Partnership invested in 10.27M shares. Westpac Banking invested in 0.02% or 14,645 shares. Philadelphia Tru Communications owns 9,555 shares. Franklin Incorporated invested in 1.69 million shares or 0.06% of the stock. Glg Prtn Lp invested 0.26% of its portfolio in Xilinx, Inc. (NASDAQ:XLNX). Dekabank Deutsche Girozentrale invested in 238,799 shares. Capital Invsts has 2.69M shares. Levin Capital Strategies Ltd Partnership has 3,000 shares. Oppenheimer Asset Mngmt owns 13,985 shares or 0.03% of their US portfolio. Conning holds 417,570 shares. Peapack Gladstone Corporation holds 0.01% or 3,535 shares.

Among 23 analysts covering Xilinx Inc. (NASDAQ:XLNX), 8 have Buy rating, 2 Sell and 13 Hold. Therefore 35% are positive. Xilinx Inc. had 57 analyst reports since July 24, 2015 according to SRatingsIntel. Barclays Capital upgraded Xilinx, Inc. (NASDAQ:XLNX) on Tuesday, July 18 to “Equal-Weight” rating. The firm has “Buy” rating given on Monday, September 14 by Goldman Sachs. The rating was maintained by Argus Research with “Buy” on Thursday, October 15. The firm earned “Buy” rating on Wednesday, October 11 by KeyBanc Capital Markets. The firm has “Underweight” rating by Barclays Capital given on Wednesday, January 18. The rating was maintained by Jefferies on Thursday, August 31 with “Buy”. The stock of Xilinx, Inc. (NASDAQ:XLNX) earned “Hold” rating by Topeka Capital Markets on Thursday, October 15. The firm earned “Buy” rating on Wednesday, November 15 by KeyBanc Capital Markets. The rating was upgraded by Goldman Sachs on Friday, January 5 to “Buy”. As per Wednesday, October 12, the company rating was downgraded by Robert W. Baird.

Analysts await Xilinx, Inc. (NASDAQ:XLNX) to report earnings on January, 24. They expect $0.63 EPS, up 21.15% or $0.11 from last year’s $0.52 per share. XLNX’s profit will be $158.10 million for 30.22 P/E if the $0.63 EPS becomes a reality. After $0.65 actual EPS reported by Xilinx, Inc. for the previous quarter, Wall Street now forecasts -3.08% negative EPS growth.

Fayez Sarofim & Company increased Microsoftcorp (NASDAQ:MSFT) stake by 241,998 shares to 6.83M valued at $508.61M in 2017Q3. It also upped S&Pglobalinc. stake by 2,630 shares and now owns 984,717 shares. Alphabetinc.Classc was raised too.

Since August 3, 2017, it had 0 insider purchases, and 5 selling transactions for $15.35 million activity. GAVRIELOV MOSHE sold 28,600 shares worth $2.05 million. Hover-Smoot Scott also sold $754,957 worth of Xilinx, Inc. (NASDAQ:XLNX) on Thursday, August 3.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts